🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

x.com/i/article/1927…

What if you could fund breakthrough science with startup velocity and investor-grade alignment? That’s LIFE. User-centric. Permissionless. Mission-led.

Not all RWAs are created equal. We’re unlocking a new asset class: tokenized health IP. It’s pre-market, regulated, and high-impact. Then we build structured yield around it with lending and funding protocols. Invest in science before it’s on Robinhood.

Scientific Research Funding is broken. 90% of life science research dies in the valley of death. LIFE will bring liquidity to those innovations, through funding, lending, and yield.

Yield in DeFi, backed by health IP. Equity funding → IP shares IP shares → collateral Collateral → yield That’s how we tokenize innovations.

Biotech stocks = high risk. VC = closed doors. Retail = left behind. LIFE lets anyone back early-stage health tech with as little as $50. You shouldn’t need a fund to fund the future.

Researchers join LIFE to: 1. Get equity funding without chasing VCs 2. Borrow against IP without dilution 3. Join a network focused on translating science into products Let’s accelerate what matters.

Why LIFE? We tokenize early-stage life science technologies that don't get VC attention. Then we make them investable from $50. The future is fractional, not gated.

Life sciences is the biggest RWA market no one’s tokenized, until now. Pre-market IP → permissionless funding → liquid exposure. lifedao.io

People often ask why I don’t just open a traditional VC fund. Raise capital. Take a management fee. Run it like everyone else. I thought about this a lot. Especially after a long conversation with Gui yesterday. But the truth is, I’ve seen too many impactful

Lending against health IP? Yes. LIFE underwrites IP-backed loans and gives investors real yield from actual innovation. We’re entering an $18B+ RWA market, bringing health IP into the fold with asymmetric upside and real-world impact.

Today’s healthcare system profits from sickness, not prevention. LIFE is building liquidity for the opposite: early-stage IP that keeps people healthy from the start. A market built for impact, not illness.

There's incredible work in DeSci happening to cure diseases. We think prevention deserves attention too. LIFE tokenizes IP from early-stage screening tech, diagnostics, and AI into RWAs, so anyone can back tech that keeps us healthy. Let's stop diseases before they even

Most preventive IP never makes it past the lab. Not because it doesn’t work, but because sickness pays 10x more. We are creating a new market that does.

👀

It’s National Call Your Doctor Day. But what if we funded the tech that keeps you from needing one? LIFE brings early-stage preventive health IP to the RWA market—so investors can back the future of staying healthy.

Real-world assets (RWAs) have become DeFi’s answer to sustainable yield. But most of what we see on-chain today looks the same: real estate, credit notes, short-term debt. Why? Because these assets are easy to value and already have predictable cash flows. They’re safe. But

What if LIFE went beyond DeSci? Tokenized real estate income, carbon credits, IP royalties. Sustainable real-world yield. Permissionless. Liquid.

RWAs are moving on-chain. But complexity doesn’t scale. At LIFE, we abstract the hard part: ✅ Path-to-Market Timelines ✅ Risk Models ✅ Investment Access into simple, liquid, investable assets.